Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

Nature Immunology

Volumn 6, Issue 8, 2005, Pages 810-818

  Zajonc, Dirk M ^a   Cantu III, Carlos ^a   Mattner, Jochen ^b   Zhou, Dapeng ^b   Savage, Paul B ^c   Bendelac, Albert ^b   Wilson, Ian A ^a   Teyton, Luc ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; NATURAL KILLER CELL RECEPTOR; ALPHA-GALACTOSYLCERAMIDE; CD1 ANTIGEN; GALACTOSYLCERAMIDE; GLYCOSPHINGOLIPID; LIGAND; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; RECOMBINANT PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; ANIMAL; BIOSYNTHESIS; CELL WALL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; FLOW CYTOMETRY; HEAT; IMMUNOLOGY; ISOELECTRIC FOCUSING; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MUTATION; NATURAL KILLER CELL; PHYSIOLOGY; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; TEMPERATURE; TH1 CELL; TH2 CELL; TIME; X RAY CRYSTALLOGRAPHY;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD1; CELL WALL; CRYSTALLOGRAPHY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; GLYCOSPHINGOLIPIDS; HEAT; HUMANS; ISOELECTRIC FOCUSING; KILLER CELLS, NATURAL; LIGANDS; LIPIDS; LYMPHOCYTE ACTIVATION; MICE; MODELS, CHEMICAL; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; TEMPERATURE; TH1 CELLS; TH2 CELLS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 23944448650     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1224     Document Type: Article

References (61)

1. Kronenberg, M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2004).
2. Vincent, M.S. et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163-1168 (2002).
3. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
4. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
5. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
6. Wu, D. et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA 102, 1351-1356 (2005).
7. Bendelac, A., Bonneville, M. & Kearney, J.F. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1, 177-186 (2001).
8. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101, 10685-10690 (2004).
9. a14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
10. Omae, F. et al. DES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine. Biochem. J. 379, 687-695 (2004).
11. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267-279 (2003).
12. Hermans, I.F. et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171, 5140-5147 (2003).
13. H2 bias of natural killer T cells. Nature 413, 531-534 (2001).
14. Goff, R.D. et al. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 126, 13602-13603 (2004).
15. Yu, K.O. et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 102, 3383-3388 (2005).
16. (bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity 14, 231-242 (2001).
17. Cantu, C., III, Benlagha, K., Savage, P.B., Bendelac, A. & Teyton, L. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J. Immunol. 170, 4673-4682 (2003).
18. Zeng, Z. et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345 (1997).
19. Zajonc, D.M., Elsliger, M.A., Teyton, L. & Wilson, I.A. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å. Nat. Immunol. 4, 808-815 (2003).
20. Moody, D.B., Zajonc, D.M. & Wilson, I.A. Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 5, 387-399 (2005).
21. Gadola, S.D. et al. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3, 721-726 (2002).
22. Batuwangala, T. et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172, 2382-2388 (2004).
23. Scott, C.A., Garcia, K.C., Carbone, F.R., Wilson, I.A. & Teyton, L. Role of chain pairing for the production of functional soluble I-A major histocompatibility complex class II molecules. J. Exp. Med. 183, 2087-2095 (1996).
24. Apostolopoulos, V. et al. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: A novel use of alternative anchors. J. Mol. Biol. 318, 1307-1316 (2002).
25. Zajonc, D.M. et al. Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22, 209-219 (2005).
26. Brossay, L. et al. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 161, 5124-5128 (1998).
27. Burdin, N. et al. Structural requirements for antigen presentation by mouse CD1. Proc. Natl. Acad. Sci. USA 97, 10156-10161 (2000).
28. α14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169, 1340-1348 (2002).
29. α14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. USA 101, 12254-12259 (2004).
30. α18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 100, 1849-1854 (2003).
31. Parekh, V.V. et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids. J. Immunol. 173; 3693-3706 (2004).
32. Ortaldo, J.R. et al. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol. 172, 943-953 (2004).
33. Koch, M. et al. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. advance online publication 10 July 2005.
34. d peptide complexes. Immunity 8, 553-562 (1998).
35. Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M. & Chapman, P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003).
36. Amprey, J.L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904 (2004).
37. Zhou, D. et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527 (2004).
38. Van Rhijn, I. et al. CD1d-restricted T cell activation by nonlipidic small molecules. Proc. Natl. Acad. Sci. USA 101, 13578-13583 (2004).
39. - T cells in mice and humans. J. Exp. Med. 180, 1097-1106 (1994).
40. - NKT cells with distinct TCR αβ repertoires and differential distribution in lymphoid tissues. J. Immunol. 165, 2481-2490 (2000).
41. Garcia, K.C., Teyton, L. & Wilson, I.A. Structural basis of T cell recognition. Annu. Rev. Immunol. 17, 369-397 (1999).
42. Wu, L.C., Tuot, D.S., Lyons, D.S., Garcia, K.C. & Davis, M.M. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418, 552--556 (2002).
43. Piel, J. et al. Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. Proc. Natl. Acad. Sci. USA 101, 16222-16227 (2004).
44. α18 natural T cell activation in vivo. J. Immunol. 174, 4696-4705 (2005).
45. Moody, D.B., Besra, G.S., Wilson, I.A. & Porcelli, S.A. The molecular basis of CD1-mediated presentation of lipid antigens. Immunol. Rev. 172, 285-296 (1999).
46. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
47. Otwinowski, Z. & Minor, W. HKL: Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 1307-326 (1997).
48. Vagin, A.A. & Teplyakov, A. MOLREP: An automated program for molecular replacement. J. Appl. Cryst. 30, 1022-1025 (1997).
49. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum likelihood method. Acta Crystallogr. D53, 240-255 (1997).
50. Jones, T.A., Zou, J.Y., Cowan, S. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A47, 110-119 (1991).
51. Schuttelkopf, A.W. & van Aalten, D.M. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D60, 1355-1363 (2004).
52. Kleywegt, G.J. & Jones, T.A. Homo crystallographicus-quo vadis?. Structure (Camb) 10, 465-472 (2002).
53. Stanfield, R.L., Ghiara, J.B., Ollmann Saphire, E., Profy, A.T. & Wilson, I.A. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. Virology 315, 159-173 (2003).
54. Lovell, S.C. et al. Structure validation by Cα geometry: ψ,φ and Cβ deviation. Proteins 50, 437-450 (2003).
55. DeLano, W. The PyMOL Molecular Graphics System. http://www.pymol.org. (2002).
56. Kraulis, P.J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24, 946-950 (1991).
57. Baker, N.A., Sept, D., Joseph, S., Holst, M.J. & McCammon, J.A. Electrostatics of nanosystems: Application to microtubules and the ribosome, Proc. Natl. Acad. Sci. USA 98, 10037-10041 (2001).
58. Merritt, E.A. & Bacon, D.J. Raster3D: Photorealistic molecular graphics. Methods Enzymol. 277, 505-524 (1997).
59. Jahng, A. et al. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957 (2004).
60. CCP4. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760-763 (1994).
61. α14 NKT cells. Int. Immunol. 13, 853-861 (2001).